Chaoju Eye Care Wins Three-Year Waiver to Appoint Executive Director as Joint Company Secretary

Chaoju Eye Care Holdings Ltd. ( (HK:2219) ) has provided an update.

Chaoju Eye Care Holdings has appointed executive director Zhang Guangdi as joint company secretary for a three-year term effective 7 January 2026, alongside existing joint company secretary Lo Wai Kin Kent. Zhang, who has extensive management experience within the group and a background in financial management and hospital operations, will combine this new governance role with his current responsibilities in the group’s investment and Hong Kong eye care businesses.

Because Zhang does not formally meet the Hong Kong Listing Rules’ professional qualification requirements for a company secretary, the Stock Exchange has granted Chaoju a three-year waiver from strict compliance with Rules 3.28 and 8.17, on the condition that Zhang is assisted by Lo and that the waiver can be revoked in the event of material Listing Rules breaches. The arrangement strengthens continuity in the company’s senior management and corporate governance structure while placing regulatory safeguards around compliance during the waiver period.

The most recent analyst rating on (HK:2219) stock is a Hold with a HK$3.00 price target. To see the full list of analyst forecasts on Chaoju Eye Care Holdings Ltd. stock, see the HK:2219 Stock Forecast page.

More about Chaoju Eye Care Holdings Ltd.

Chaoju Eye Care Holdings Ltd. is a China-based ophthalmic medical services group operating eye hospitals and related eye care businesses. The company focuses on providing comprehensive eye diagnosis and treatment, refractive correction and other specialized ophthalmic services across its network in mainland China and Hong Kong.

Average Trading Volume: 472,173

Technical Sentiment Signal: Sell

Current Market Cap: HK$1.9B

For an in-depth examination of 2219 stock, go to TipRanks’ Overview page.